baber/WOPTO huggingface dataset:
Patent MX-2018006428-A (MX)
Title: Synthesis of magnesium dichloride support for the ast off-line zn catalyst with a plug flow reactor (pfr).
Inventor: QINYAN WANG
IPC: C01F5/30
Filed: 2016-12-05
Abstract: The various embodiments of the invention provide, a magnesium dichloride support and the magnesium titanium polymerization procatalyst made therefrom, and methods for making and using the same.
Patent MX-2018009802-A (MX)
Title: Novel compositions and therapeutic methods.
Inventor: Suchismita ACHARYA
IPC: C07H5/08
Filed: 2017-03-30
Abstract: The present invention is directed to novel products, variants, pharmaceutically acceptable salts and prodrugs thereof, and medical use of such compounds for the treatment and/or management of sepsis, septicemia, septic shock, ocular infection, ocular inflammation, ocular angiogenesis, rheumatoid arthritis (RA), atherosclerosis, inflammatory bowel diseases (IBD), asthma, chronic obstructive pulmonary disease, fever syndromes, cachexia, psoriasis, autoimmune diseases, cardiac diseases, retinoblastoma, cancer and/or any disorder associated with inflammation, immunomodulation and microbial infection.
Patent MX-2018012504-A (MX)
Title: Chagas antigens and antibodies and compositions, methods and uses thereof.
Inventor: GREGORY ALAN STOLOFF
IPC: C07K14/44
Filed: 2017-04-18
Abstract: The present specification discloses Trypanosoma antigens, immunogenic compositions and medicaments comprising such Trypanosoma antigens, methods and uses for such Trypanosoma antigensand immunogenic compositions for treating a Trypanosoma-based disease.
Patent MX-2018013598-A (MX)
Title: Rod de-tensioning device and methods of operating the same.
Inventor: ROBERT LINDYBERG
IPC: E02B8/00
Filed: 2017-05-09
Abstract: A rod detensioning unit including a gripping unit removal device that engages a gripping unit on a rod, a chair frame configured to engage a rod, a rod tensioning unit that applies tension to an external portion of the rod to remove load from the gripping unit, a load cell unit that measures a tension level applied to the rod by the tensioning unit, a plate gripping unit that engages the rod and secures the chair frame, rod tensioning unit, load cell and plate gripping unit to the rod, a drive unit that engages the gripping unit removal device, and an extension unit affixed to the external portion of the rod when the original external rod length is too short to accommodate the de-tensioning unit.
Patent MX-2018016199-A (MX)
Title: An electric vehicle.
Inventor: Pritam Popatrao KHAMKAR
IPC: B60L1/00
Filed: 2018-12-19
Abstract: The present invention provides an electric vehicle comprising a chassis including a rear frame portion; an electric motor as prime mover connected to said chassis and to a rear drive transmission system; an electric battery module for powering the electric motor comprising at least one battery and its frame structure mounted to the chassis; wherein a portion of said electric motor is disposed below the rear frame portion of the chassis, such location of the portion of the electric motor being convenient to enable cooling, conveniently ram air cooling..
Patent MX-2018016398-A (MX)
Title: Apparatus and method for monitoring nitric oxide delivery.
Inventor: ACKER JARON
IPC: A61M16/12
Filed: 2014-05-07
Abstract: Described is an apparatus for monitoring nitric oxide delivery, wherein such apparatus comprises an indicator to inform a user of the apparatus when the flow of breathing gas rises above or falls below a predetermined level or range. Also described is a method of monitoring nitric oxide delivery, wherein the flow of breathing gas is measured and displayed. In some embodiments, an alert is provided when the flow of breathing gas rises above or falls below a predetermined level or range.
Patent MX-2019004286-A (MX)
Title: Method for the synthesis of fluor-graphene with high proportion of fluor and low oxygen content.
Inventor: RAMÓN RAYGOZA EDGAR DAVID
IPC: C01B32/184
Filed: 2019-04-12
Abstract: The present invention relates to a method for the synthesis of flour-graphene that allows increasing the proportion of fluorine in the final compound while limiting the presence of oxygen, thus preserving a carbon/fluorine ratio of up 0.3 to 0.4, limiting the concentration of oxygen remaining in the compound below of 7.5%.
Patent MX-2019005254-A (MX)
Title: Process for purification of pyrazolpyridazines.
Inventor: JOCHEN DIETZ
IPC: C07D403/12
Filed: 2017-10-27
Abstract: The present invention relates to a process for the purification of pyrazolpyridazines of formula I, wherein the variables are as defined in the specification, by adding HCl to a solution of the pyra- zolpyridazine in an inert solvent under non-aqueos conditions, effecting crystallization of the HCl-salt, isolating the resulting precipitate.
Patent MX-2019005984-A (MX)
Title: Flexibly-mounted evacuation channels in collapsible bags.
Inventor: JAMES W JOHNSON
IPC: B67D7/78
Filed: 2015-11-17
Abstract: The present invention relates to a mounting for connecting at least one peripherally- connected evacuation channel to the spout of a flexible bag and more particularly to a flexible mounting for connecting such at least one evacuation channel. The present invention relates to a mounting for connecting at least one peripherally- connected evacuation channel to the spout of a flexible bag and more particularly to a flexible mounting for connecting such at least one evacuation channel. Biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) is processed to produce useful intermediates and products, such as poly carboxylic acids and poly carboxylic acid derivatives.
Patent MX-2019006942-A (MX)
Title: Non-peptide oxytocin receptor agonists.
Inventor: MICHAEL KASSIOU
IPC: A61P27/00
Filed: 2017-12-12
Abstract: Disclosed herein are compounds according to Formula I; a pharmaceutical composition including, consisting essentially of, or consisting of: a pharmaceutically acceptable compound of Formula I and a pharmaceutically acceptable carrier, diluent, or excipient; the use of compounds of Formula I in the preparation of a medicament; and a method including administering a pharmaceutical compositions comprising the compound of Formula I to a patient. The compounds, compositions, use, and methods are directed to the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders.
Patent MX-2019007744-A (MX)
Title: Aqueous polymer dispersion and process of making the same.
Inventor: XIAOHONG YANG
IPC: C09D133/08
Filed: 2016-12-28
Abstract: An aqueous dispersion of a multistage polymer and an aqueous coating composition comprising the aqueous dispersion and providing coating films with good scratch resistance and balanced properties.
Patent MX-2019011500-A (MX)
Title: Adjustable p-clamp with multiple mounting options.
Inventor: TOLL MICHAEL
IPC: F16B2/10
Filed: 2019-09-26
Abstract: A mounting bracket assembly and method to secure elongate items, such as wires, cables, or other bundles items to a support structure. The mounting bracket assembly may include a first portion defining a tie aperture configured to receive an elongate cable tie and a second portion defining a mounting aperture configured to receive an attachment feature therethrough. The mounting bracket assembly may also include a clamp member shaped to enclose an elongate member, a locking mechanism having a tongue defining a plurality of serrations and a slotted opening where the tongue member is releasably received in the slotted opening, a wedge-shaped pawl having a plurality of teeth that interlock with the serrations, and a mounting member extending from the clamp member defining a mounting aperture configured to receive an attachment feature.
Patent MX-2019013019-A (MX)
Title: USE OF 3, 16-DIACETATE OF 26-AZIDO-22-OXOCOLEST-5-3ß, 16ß-DIYL AS AN ANTI-CANCER AGENT.
Inventor: ZEFERINO DÍAZ Reyna
IPC: C07J9/00
Filed: 2019-10-31
Abstract: The present invention discloses the pharmaceutical use of the compound 26-azido-22-oxo-cholest-5-en-3ß, 16ß-diyl 3,16-diacetate for treating hormone-dependent cancer. Said compound demonstrated its anti-neoplastic activity through the induction of caspase-3-dependent apoptosis in tumor cells.
Patent MX-2019013031-A (MX)
Title: Rapamycin analogs as mtor inhibitors.
Inventor: WANG GANG
IPC: A61P37/00
Filed: 2018-05-01
Abstract: The present disclosure relates to rapamycin analogs of the general Formula (I). The compounds are inhibitors of mTOR and thus useful for the treatment of cancer, immune-mediated diseases and age related conditions.
Patent MX-2019013817-A (MX)
Title: Cup-cover-type fan and water cup.
Inventor: XU WENLONG
IPC: A47G19/22
Filed: 2018-01-15
Abstract: Disclosed is a cup-cover-type fan, comprising a fan blade assembly, a control component connected to the fan blade assembly, a power supply (103), and further comprising a base (1), wherein the control component and the power supply (103) are mounted inside the base (1), and the fan blade assembly is disposed on an upper portion of the base (1); the fan blade assembly comprises a fan cover (6) and a blade wheel portion (60) mounted inside the fan cover (6), the fan cover (6) is rotationally connected to the base (1) via a connecting structure, and the fan cover (6) is rotated along the connecting structure for unfolding and folding purposes, in order to realize disengagement and engagement of same with an upper surface of the base (1); and the base (1) is formed with a covering end for covering a cup mouth of a cup body. The fan cover of the above-mentioned cup-cover-type fan is rotated along the connecting structure for unfolding and folding purposes, in order to realize disengagement and engagement of same with the upper surface of the base for adjusting the wind direction.
Patent MX-2020001871-A (MX)
Title: Process for producing (meth)acrylates from glycerol carbonate.
Inventor: PETZOLDT JOCHEN
IPC: C07D317/36
Filed: 2018-08-16
Abstract: Process for producing esters of (meth)acrylic acid or a derivative thereof by reaction of (meth)acrylic acid or a derivative thereof with glycerol carbonate in the presence of at least one enzyme which catalyzes the esterification reaction, in the absence of a solvent and at a reaction temperature of 10Â°C to 150Â°C.
Patent MX-2020005384-A (MX)
Title: Utility tower leveling apparatus and method.
Inventor: CHAPUT LUKE J
IPC: E04H12/34
Filed: 2018-11-26
Abstract: A lattice type transmission tower leveling device for leveling a transmission tower with respect to a ground surface. The tower leveling device includes a series of side supports positioned at first and second sides of the transmission tower. The leveling device also includes a support beam that is secured to a third side of a transmission tower that is leaning and a second support beam that is secured to a fourth side of the transmission tower opposite the third side. The device further includes a series of brace members that are interconnected to form a lattice brace structure. The lattice brace structure is coupled to the upright members of the transmission tower. The tower leveling device also includes a lift beam secured to the side supports of the tower and a series of hydraulic cylinders that extend from the lift beam to the first support beam. Linear movement of the cylinders causes the transmission tower to rotate about the axis of rotation so that the tower can be leveled and new tower base supports can be installed.
Patent MX-2020006180-A (MX)
Title: Igm monoclonal antibodies recognizing the dna binding domain of rest in its native form.
Inventor: MEDINA FLORES YOLANDA
IPC: G01N33/577
Filed: 2020-07-13
Abstract: The present invention relates to the generation of a hybridoma producing monoclonal antibodies of the IgM class, which recognizes the DNA-binding domain of the transcriptional factor REST. Said hybridoma is deposited in the Collection of Microorganisms of the National Center for Genetic Resources of INIFAP, with the name CYK_uREST19 and deposit number CM-CNRG-TB104. Also, it consists of the fusion of 750 spleen cells from an immunized Balb/c mouse and X63Ag8.653 cells from mouse myeloma. Herein, the antibody obtained consists of five immunoglobulin monomers with a mass of up to 150kDa and two antigenic recognition sites. Further, the obtained antibody recognizes native REST isoforms and is useful for immunostaining 755 in samples of precancerous and cancerous lesions of the uterine cervix, to aid in the diagnosis and/or prognosis of cervical cancer. Additionally, it is useful in the diagnosis and prognosis of other types of cancer and neurodegenerative diseases. Finally, it is useful in ELISA, Immunoprecipitation, and dot blot tests.
Patent MX-2020006830-A (MX)
Title: Amphiphilic copolymers as surface modifiers for production of improved calcium carbonate powders.
Inventor: FRITZEN PETRA
IPC: C09B67/08
Filed: 2018-12-21
Abstract: This disclosure describes a process for producing a surface-modified calcium carbonate, the process comprising contacting a calcium carbonate or precursor thereof with at least one amphiphilic copolymer comprising hydrophilic subunits and hydrophobic subunits, in which the hydrophilic subunits derive from at least one ethylenically-unsaturated compound comprising a carboxylic acid group or salt or derivative thereof;the hydrophobic subunits derive from at least one ethylenically-unsaturated compound comprising a hydrophobic group; and the amphiphilic copolymer has a hydrophilic-lipophilic balance ranging from about 1 to about 40. Surface-modified calcium carbonates obtained from the process are also described, as well as compositions containing the surface-modified calcium carbonates.
Patent MX-2020007578-A (MX)
Title: Protecting a message transmitted between core network domains.
Inventor: MARTINEZ DE LA CRUZ PABLO
IPC: H04W12/02
Filed: 2019-02-15
Abstract: Network equipment (300, 400) is configured for use in one of multiple different core network domains of a wireless communication system (10). The network equipment (300, 400) is configured to receive a message (60) that has been, or is to be, transmitted between the different core network domains. The network equipment (300, 400) is also configured to apply inter-domain security protection to, or remove inter-domain security protection from, one or more portions of the content of a field in the message according to a protection policy (80). The protection policy (80) includes information indicating to which one or more portions of the content inter-domain security protection is to be applied or removed. The network equipment (300, 400) is also configured to forward the message (60), with inter-domain security protection applied or removed to the one or more portions, towards a destination of the message (60).
Patent MX-2020008622-A (MX)
Title: Cascade varistor having improved energy handling capabilities.
Inventor: BEROLINI MARIANNE
IPC: H01C7/10
Filed: 2019-03-04
Abstract: A varistor is provided having a rectangular configuration defining first and second opposing end surfaces offset in a lengthwise direction. The varistor may include a first terminal adjacent the first opposing end surface and a second terminal adjacent the second opposing end surface. The varistor may include an active electrode layer including a first electrode electrically connected with the first terminal and a second electrode electrically connected with the second terminal. The first electrode may be spaced apart from the second electrode in the lengthwise direction to form an active electrode end gap. The varistor may include a floating electrode layer including a floating electrode. The floating electrode layer may be spaced apart from the active electrode layer in a height-wise direction to form a floating electrode gap. A ratio of the active electrode end gap to the floating electrode gap may be greater than about 2.
Patent MX-2020010184-A (MX)
Title: Heterocyclic compound.
Inventor: YOSHIDA YOSHINORI
IPC: C12N5/077
Filed: 2019-03-28
Abstract: The present invention provides a heterocyclic compound having an activity to enhance the maturation of a cardiomyocyte. A compound represented by formula (I) [wherein each symbol is as defined in the description] or a salt thereof has an activity to enhance the maturation of a cardiomyocyte and is therefore useful as a cardiomyocyte maturation enhancer.
Patent MX-2020012932-A (MX)
Title: Novel compounds for diagnosis.
Inventor: MOLETTE JÉRÔME
IPC: A61K31/519
Filed: 2019-06-07
Abstract: The present invention relates to novel compounds that can be employed in the diagnosis, monitoring of disease progression or monitoring of drug activity of a group of disorders and abnormalities associated with alpha-synuclein (Î±-synuclein, A-synuclein, aSynuclein, a- synuclein, A-syn, Î±-syn, aSyn, SNCA, Non-amyloid beta component of Alzheimer's disease (AD) amyloid plaques, Non-A4 component of amyloid precursor, NACP) aggregates including, but not limited to, Lewy bodies and/or Lewy neurites, such as Parkinson's disease (PD). The instant compounds are particularly useful in the diagnosis of the preclinical state of such a disorder, monitoring residual disorder, or predicting the responsiveness of a patient who is suffering from such a disorder to the treatment with a certain medicament.
Patent MX-2020013301-A (MX)
Title: Methods and compositions for preventing or treating calciphylaxis.
Inventor: TUMLIN JAMES A
IPC: A61K31/05
Filed: 2019-06-07
Abstract: The invention provides methods and compositions for preventing or treating (<i>e.g</i>., slowing the progression of, arresting, and/or reversing) calciphylaxis in a subject in need thereof and, more particularly, the invention relates to methods of using menaquinone-7 (MK-7) and/or menaquinol-7 (MKH2-7) for preventing or treating calciphylaxis in a subject with one or more of the following: diabetes, chronic kidney disease, end stage renal failure, and COPD or a subject undergoing hemodialysis and/or receiving anticoagulant therapy and/or statin therapy.
Patent MX-2020013601-A (MX)
Title: Cancer-specific t-cell receptors.
Inventor: SEWELL ANDREW
IPC: A61K38/17
Filed: 2019-06-25
Abstract: The present disclosure relates to a new anti-cancer peptide; a vector encoding same; a pharmaceutical composition or immunogenic agent or bispecific or vaccine comprising said anti-cancer peptide; use of said anti-cancer peptide, vector, pharmaceutical composition, immunogenic agent, bispecific or vaccine to treat cancer; a method of treating cancer using said anti-cancer peptide, vector, pharmaceutical composition, immunogenic agent, bispecific or vaccine; and a combination therapeutic for the treatment of cancer comprising said anti-cancer peptide, vector, pharmaceutical composition, immunogenic agent, bispecific or vaccine.
Patent MX-2021001747-A (MX)
Title: Enclosed connection systems for forming an enclosed connection between conductors, and methods including same.
Inventor: NEWMAN JOHN ANTHONY
IPC: H01R11/11
Filed: 2021-02-12
Abstract: An enclosed connection system for mechanically and electrically connecting first and second cables each including an elongate electrical conductor covered by an insulation layer, includes an electrical connector, an enclosure, and a protective end cap. The electrical connector is configured to form a connection with the first and second cables wherein the conductors of the first and second cables are electrically connected by the electrical connector. The enclosure is configured to receive and cover the connection and to protect the electrical connector. The enclosure includes a plurality of enclosure ports each configured to receive a cable. The protective end cap is configured to selectively cover at least a selected one of the enclosure ports.
Patent MX-2021003549-A (MX)
Title: Dual specific antibodies.
Inventor: FUH GERMAINE
IPC: C07K16/46
Filed: 2016-05-19
Abstract: The invention provides dual specific antibodies and methods of making and using such antibodies. In general, the dual specific antibodies are generated by identification of a monospecific antibody having light chain variable region VL residues that are electrostatic or hydrophobic and altering the nucleic acid sequence encoding one or more solvent accessible residues in the VH of the antibody either alone or in combination with alteration of the nucleic acid sequence encoding the VL of the antibody. The altered VH and the VL are expressed and dual specific antibodies, or antigen-binding fragments thereof, are selected. Exemplary dual specific antibodies are also provided as well as methods of using the antibodies.
Patent MX-2021003602-A (MX)
Title: Hfo-1234ze and hfo-1234yf compositions and processes for producing and using the compositions.
Inventor: NAPPA MARIO JOSEPH
IPC: C07C21/18
Filed: 2019-10-25
Abstract: A fluoropropene composition comprising Z-1,3,3,3-tetrafluoropropene, Eâ1,3,3,3âtetrafluoropropene, 2,3,3,3-tetrafluoropropene, and optionally 1,1,1,3,3âpentafluoropropane wherein the 2,3,3,3-tetrafluoropropene being present in an amount of 0.001 to 1.0%. A method of producing the fluoropropene, methods for using the fluoropropene and the composition formed are also disclosed.
Patent MX-2021006923-A (MX)
Title: Powder application device and method for producing stiffening elements from pulverous material.
Inventor: AMES SEBASTIAN
IPC: A43B23/17
Filed: 2019-12-04
Abstract: The invention relates to a powder application device for applying at least partially meltable powder (12) onto a providing element (24) for the production of stiffening elements (30), which powder application device has a powder container (10). A template (16) for defining a basic form of a stiffening element (30) to be produced is provided in the region of an outlet (14) of the powder container (10). Furthermore, a closing apparatus (18) is provided for opening and closing the outlet (14). In order to produce stiffening elements (30) having different stiffness, in particular barrier elements (28) connected to the template (16) are provided. By means of the barrier elements (28), powder supply to the providing element (24) is reduced such that a stiffening element (30) having regions (34) of different material thickness is formed. The invention further relates to a method for producing a stiffening element of this type.
Patent MX-2021007465-A (MX)
Title: Methods and apparatus of video coding for deriving affine motion vectors for chroma components.
Inventor: WANG XIANGLIN
IPC: H04N19/132
Filed: 2019-12-12
Abstract: Video coding methods and apparatuses are provided. A set of two or more pictures is coded. The set includes at least a first picture coded with a first spatial resolution, and a second picture coded with a second spatial resolution different from the first spatial resolution. The set of two or more pictures is stored in a decoded picture buffer based on corresponding spatial resolutions. The set of two or more pictures stored in the decoded picture buffer is used as a set of reference pictures for coding one or more successive pictures subsequent to the set of two or more pictures. The set of two or more pictures is incorporated into a reference picture list that contains pictures with at least two different spatial resolutions.
Patent MX-2021009517-A (MX)
Title: Optimized method for industrial exploitation of unicellular red algae.
Inventor: CAGNAC OLIVIER
IPC: C12N1/12
Filed: 2020-02-07
Abstract: The present invention relates to a method for culturing unicellular red algae (URA) optimized for the valorization of culture products, both the biomass obtained and the phycocyanins which are extracted or the other culture products such as porphyrins or protein extracts.
Patent MX-2021009764-A (MX)
Title: Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof.
Inventor: LAM PHILIP
IPC: C07D401/04
Filed: 2020-02-13
Abstract: The present disclosure provides a compound of Formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R1, R2, Rx, X1, X2, X3, n, n1,and q are as defined herein, and methods of making and using same.